Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.5982-0.0618 (-1.33%)
As of 11:51AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
181,035
485,424
375,203
233,155
11,612
Cost of revenue
21,799
66,436
45,516
27,143
-
Gross profit
159,236
418,988
329,687
206,012
-
Operating expenses
Research development
134,160
107,879
62,062
29,393
10,113
Selling general and administrative
69,022
66,755
48,761
15,752
4,012
Total operating expenses
223,815
191,923
107,788
41,661
13,954
Operating income or loss
-64,579
227,065
221,899
164,351
-2,343
Interest expense
-
4,045
5,225
6,511
209.196
Total other income/expenses net
-
-
-855
-300
186.056
Income before tax
-39,858
239,099
219,149
157,833
-2,211
Income tax expense
10,306
80,580
65,685
38,915
-
Income from continuing operations
-50,164
158,519
153,464
118,918
-2,211
Net income
-50,164
158,519
153,464
118,918
-2,211
Net income available to common shareholders
-50,164
158,519
153,464
118,918
-2,211
Basic EPS
-
0.56
0.56
0.53
-0.01
Diluted EPS
-
0.50
0.48
0.45
-0.01
Basic average shares
-
285,057
275,764
159,195
215,415
Diluted average shares
-
314,827
318,294
263,130
237,724